From GlobeNewswire: 2024-11-08 08:58:00

The Proteomics Market was valued at USD 30.61 billion in 2023 and is projected to reach USD 96.35 billion by 2032, with a CAGR of 13.61% during 2024-2032. Advancements in personalized medicine and drug discovery are driving market growth, especially in biomarker discovery for tailored treatments. Rising chronic disease prevalence, particularly cancer, also contributes to market expansion.

Key drivers for the Proteomics Market include improved technologies for precise protein analysis, personalized medicine adoption, and biomarker discovery for diseases like cancer. The market is supported by factors like mass spectrometry utilization, AI and ML integration, and public/private investments in research. Proteomics is crucial for clinical assays, drug development, and personalized medicine, especially in finding molecular targets and measuring therapeutic responses.

In 2023, the spectrometry segment dominated the Proteomics Market due to its role in protein identification, post-translational modification detection, and protein-protein interaction analysis. Next-generation sequencing (NGS) is set for rapid growth from 2024-2032, driven by decreasing costs, faster speeds, and accuracy improvements. Strategic partnerships, like the one between Pixelgen Technologies and BioStream Co. Ltd., aim to accelerate NGS segment expansion for single-cell applications.

North America held over 46.87% of the global Proteomics Market share in 2023. The market is classified as the largest growing segment due to biotechnology advancements, precision medicine adoption, and increased focus on drug discovery. With the rising incidence of chronic diseases like cancer, the Proteomics Market is expected to continue thriving, driven by technological developments and increasing demand for biomarker discovery. The proteomics market is experiencing significant growth driven by technological advancements and increased demand for diagnostic tools. The Asia Pacific region is expected to lead this growth with a projected CAGR of 16.47% between 2024 and 2032, fueled by investments and government support. Recent innovations from companies like Agilent Technologies and Thermo Fisher Scientific are enhancing proteomics analysis, further advancing research and diagnostics in the field.



Read more at GlobeNewswire: Proteomics Market Set to Surge: Aiming for USD 96.35